The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …

Metformin was first used to treat type 2 diabetes in the late 1950s and in 2022 remains the
first-choice drug used daily by approximately 150 million people. An accumulation of …

Objective The objective of this clinical practice guideline is to provide updated and new
evidence-based recommendations for the comprehensive care of persons with diabetes …

Importance Prediabetes, an intermediate stage between normal glucose regulation and
diabetes, affects 1 in 3 adults in the US and approximately 720 million individuals …

The numerous beneficial health outcomes associated with the use of metformin to treat
patients with type 2 diabetes (T2DM), together with data from pre-clinical studies in animals …

This is an opportune time to publish the first KDIGO 2020 Clinical Practice Guideline for
Diabetes Management in Chronic Kidney Disease (CKD). Worldwide, the estimated number …

The Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for
Diabetes Management in Chronic Kidney Disease represents the first KDIGO guideline on …

Description: The Kidney Disease: Improving Global Outcomes (KDIGO) organization
developed a clinical practice guideline in 2020 for the management of patients with diabetes …

Metformin is one of the most popular oral glucose-lowering medications, widely considered
to be the optimal initial therapy for patients with type 2 diabetes mellitus. Interestingly, there …

Vitamin B12 deficiency is a common cause of megaloblastic anemia, various
neuropsychiatric symptoms, and other clinical manifestations. Screening average-risk adults …